Ismail Koubiyr, Takayuki Yamamoto, Simon Blyau, Reda A Kamroui, Boris Mansencal, Vincent Planche, Laurent Petit, Manojkumar Saranathan, Romain Casey, Aurélie Ruet, Bruno Brochet, José V Manjón, Vincent Dousset, Pierrick Coupé, Thomas Tourdias
BACKGROUND AND OBJECTIVES: Thalamic atrophy can be used as a proxy for neurodegeneration in multiple sclerosis (MS). Some data point toward thalamic nuclei that could be affected more than others. However, the dynamic of their changes during MS evolution and the mechanisms driving their differential alterations are still uncertain. METHODS: We paired a large cohort of 1,123 patients with MS with the same number of healthy controls, all scanned with conventional 3D-T1 MRI...
May 2024: Neurology® Neuroimmunology & Neuroinflammation